Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.
Psilocybin is under clinical development by Filament Health and currently in Phase I for Major Depressive Disorder.
Money Talks News on MSN2h
This Technology Could Predict Your Odds of Alzheimer’s DiseaseIt might even have the ability to predict who will get dementia. An AI computer program that analyzes speech patterns in ...
Though you might need a “keen eye” to spot early MCI, as it “involve [s] a mild decline in thinking, occurring in a setting ...
A neuroscientist describes how traditional Chinese medicine may provide modern solutions to preserving cognitive function as ...
Uncover the challenges of ensuring road safety for senior drivers with mild cognitive impairment. Learn why our healthcare system needs better monitoring and testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback